Finder

Current NHS consultant posts held

Consultant Hepatologist and Endoscopist at Royal London Hospital, Barts Health NHS Trust

Research interests

Fatty liver disease / Metabolic dysfunction associated steatotic liver disease
Pregnancy related liver diseases

Publications

? Dadey T, Lim TY, Makaronidis J, Diabetes and the Liver, Clinical Medicine (2025), doi: https://doi.org/10.1016/j.clinme.2025.100528
? Elgosbi M, Kurt AS, Londo�o MC, Caballero-Marcos A, Lim TY, Lozano JJ, et al. Hypothermic oxygenated machine perfusion influences the immunogenicity of donor livers in humans. Liver Transplant. Published online 2024. doi:10.1097/LVT.0000000000000461
? Lim TY, Perpi��n E, Londo�o MC, Miquel R, Ruiz P, Kurt AS, et al. Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans. J Hepatol. 2023;78(1):153-164. doi:10.1016/j.jhep.2022.08.035.
? Lim TY, Sanchez-Fueyo A. Chapter: Tolerance in Liver Transplantation. Textbook of Liver Transplantation. Springer, Cham. 2022. https://doi.org/10.1007/978-3-030-82930-8_45.
? Lim TY, McPhail MJ, Shah A, Mahgoub S, Nayagam J, Cramp M, et al. Sequential Cohort Analysis After Liver Transplantation Shows de Novo Extended Release Tacrolimus Is Safe, Efficacious, and Minimizes Renal Dysfunction. Transplant Direct. 2020;6(2):e528. doi:10.1097/TXD.0000000000000970.
? S�nchez-Fueyo A, Whitehouse G, Grageda N, Cramp M, Lim TY, Romano M, et al. Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation. Am J Transpl. 2020;20:1125-1136. doi:10.1111/ajt.15700.
? Gonsalkorala ES, Cannon MD, Lim TY, Penna L, Willliamson C, Heneghan MA. Non-Invasive Markers (ALBI and APRI) Predict Pregnancy Outcomes in Women With Chronic Liver Disease. Am J Gastroenterol. Published online 2018. doi:10.1038/s41395-018-0181-x.
? Lim TY, Martinez?Llordella M, Kodela E, Gray E, Heneghan MA, Sanchez?Fueyo A. Low?Dose Interleukin?2 for Refractory Autoimmune Hepatitis. Hepatology. 2018;5(5):18-21. Doi: 10.1002/hep.30059.
? Manini MA, Whitehouse G, Bruce M, Passerini M, Lim TY, Carey I, et al. Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal. Dig Liver Dis. Published online April 13, 2018. doi:10.1016/j.dld.2018.03.032.
? Lim TY, Gonsalkorala E, Cannon MD, Gabeta S, Penna L, Heaton ND, et al. Successful pregnancy outcomes following liver transplantation is predicted by renal function. Liver Transplant. 2018;(9):1-10. doi:10.1002/lt.25034.